EDIT:NASDAQ
Editas Medicine Inc
2,17 $
arrow_upward
+1,40%(+0,030) 1D
13 նոյ, 16:00:01 GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for EDIT...
Open
2,14 $
High
2,21 $
Low
2,01 $
Mkt. cap
334,92 մլն
Avg. vol.
2,42 մլն
Volume
2,79 մլն
52-wk high
3,94 $
52-wk low
1,66 $
EPS
-0,62 $
Beta
2,09
Shares outstanding
154,34 մլն
No. of employees
87
Open
2,14 $
High
2,21 $
Low
2,01 $
Mkt. cap
334,92 մլն
Avg. vol.
2,42 մլն
Volume
2,79 մլն
52-wk high
3,94 $
52-wk low
1,66 $
EPS
-0,62 $
Beta
2,09
Shares outstanding
154,34 մլն
No. of employees
87
News stories
From web sources and news partners
BigGo Finance
·
5 ժամ առաջ
Goldman Sachs Sets 8,700 S&P 500 Target for 2027, Sees 14% Upside as AI Capex Peaks
The Motley Fool
·
4 ժամ առաջ
Tesla Is Down 13% in 2026 While the S&P 500 Is Up. Here’s the 1 Catalyst Left This Year That Could Flip That.
24/7 Wall St.
·
3 ժամ առաջ
Gilead Beat the S&P 500 by More Than 25 Points in the Past Year, but $1,000 From a Decade Ago Is Still Worth Less Than $3,500
Traders Union
·
3 ժամ առաջ
Chris Ciovacco: Semiconductors SMH and S&P 500 SPY show several possible support areas
Profile
Editas Medicine, Inc., is a clinical-stage biotechnology company that is developing therapies for rare diseases using CRISPR gene editing technology. Editas Medicine headquarters is located in Cambridge, Massachusetts with additional facilities in Boulder, Colorado. Wikipedia
About Editas Medicine Inc